Back
39
Also listed as
SNNUF
OTC
Day Range
$32.06
$32.39
52-Week Range
$23.91
$38.79
Volume
601,676
50D / 200D Avg
$34.35
/
$33.93
Prev Close
$31.94
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 21.8 | 0.3 |
| P/B | 2.6 | 2.9 |
| ROE % | 11.9 | 3.7 |
| Net Margin % | 10.1 | 3.8 |
| Rev Growth 5Y % | 4.3 | 10.0 |
| D/E | 0.6 | 0.2 |
Analyst Price Target
Hold
$37.50
+16.6%
Forward P/E
14.3
Forward EPS
$2.23
EPS Growth (est.)
+0.0%
Est. Revenue
6.6 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.16
$3.06 – $3.24
|
8.3 B | 1 |
| FY2029 |
$2.95
$2.85 – $3.02
|
7.8 B | 1 |
| FY2028 |
$2.75
$2.66 – $2.82
|
7.3 B | 1 |
Key Takeaways
Revenue grew 4.34% annually over 5 years — modest growth
Earnings grew 52.05% over the past year
ROE of 11.87% — decent returns on equity
Generating 853.99M in free cash flow
PEG of 0.41 suggests growth is underpriced
Cash machine — converts 136.32% of earnings into free cash flow
Growth
Revenue Growth (5Y)
4.34%
Revenue (1Y)6.34%
Earnings (1Y)52.05%
FCF Growth (3Y)117.21%
Quality
Return on Equity
11.87%
ROIC8.75%
Net Margin10.14%
Op. Margin16.27%
Safety
Debt / Equity
0.63
Current Ratio2.57
Interest Coverage6.43
Valuation
P/E Ratio
21.83
P/B Ratio2.59
EV/EBITDA16.36
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.34% | Revenue Growth (3Y) | 5.52% |
| Earnings Growth (1Y) | 52.05% | Earnings Growth (3Y) | 54.34% |
| Revenue Growth (5Y) | 4.34% | Earnings Growth (5Y) | 4.57% |
| Profitability | |||
| Revenue (TTM) | 6.18B | Net Income (TTM) | 626.46M |
| ROE | 11.87% | ROA | 5.99% |
| Gross Margin | 68.01% | Operating Margin | 16.27% |
| Net Margin | 10.14% | Free Cash Flow (TTM) | 853.99M |
| ROIC | 8.75% | FCF Growth (3Y) | 117.21% |
| Safety | |||
| Debt / Equity | 0.63 | Current Ratio | 2.57 |
| Interest Coverage | 6.43 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 21.83 | P/B Ratio | 2.59 |
| P/S Ratio | 2.21 | PEG Ratio | 0.41 |
| EV/EBITDA | 16.36 | Dividend Yield | 0.02% |
| Market Cap | 13.67B | Enterprise Value | 16.44B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.18B | 5.81B | 5.55B | 5.22B | 5.21B |
| Net Income | 626.46M | 412.00M | 263.00M | 223.00M | 524.00M |
| EPS (Diluted) | 1.44 | 0.94 | 1.20 | 0.50 | 1.20 |
| Gross Profit | 4.20B | 4.05B | 3.82B | 3.68B | 3.67B |
| Operating Income | 1.01B | 657.00M | 425.00M | 315.00M | 593.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 10.46B | 10.35B | 9.99B | 9.97B | 10.92B |
| Total Liabilities | 5.17B | 5.09B | 4.77B | 4.71B | 5.35B |
| Shareholders' Equity | 5.29B | 5.27B | 5.22B | 5.26B | 5.57B |
| Total Debt | 3.33B | 3.32B | 3.08B | 2.87B | 3.34B |
| Cash & Equivalents | 557.00M | 619.00M | 302.00M | 350.00M | 1.29B |
| Current Assets | 4.10B | 4.42B | 4.03B | 3.86B | 4.42B |
| Current Liabilities | 1.60B | 1.53B | 2.27B | 1.72B | 2.13B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#664 of 1052
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026